Contineum Therapeutics, Inc. (CTNM) - Stock Based Compensation

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Cashflow From Financing

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Cashflow From Investment

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Capital Expenditures

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Depreciation Depletion And Amortization

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Operating Cashflow

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

SARATOGA INVESTMENT CORP. (SAR) - Shares Outstanding Diluted

SARATOGA INVESTMENT CORP.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Income Tax Expense

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Interest Expense

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Contineum Therapeutics, Inc. (CTNM) - Net Income

Contineum Therapeutics, Inc.

1Y 2Y 5Y Max Normalize Line Bar

about 2 months ago

View Ask a follow up

Load more